Multiple Sclerosis News

New MS Study Shows TYSABRI Improves Cognitive Impairment

Researchers at Spedali Civili of Brescia in Italy recently published findings in the journal PLoS One that Biogen’s Tysabri (natalizumab) can improve cognitive impairment in patients with relapsing remitting multiple sclerosis (RRMS) over the course of at least three years. The study is entitled “Natalizumab…

Mitochondria May Play a Role in MS Development and Progression

Recent attention to the role of mitochondria in the etiology of multiple sclerosis (what causes the disease) suggests that mitochondrial defects and mitochondrial structural and functional changes may contribute to the disease. Researchers studying mitochondria in multiple sclerosis believe abnormalities in mitochondrial dynamics impact cellular pathways such as inflammation and…

1200 People With Relapsing MS Needed For RPC1063, Avonex Clinical Trials

Clinical investigators worldwide are beginning to recruit 1,200 patients with relapsing multiple sclerosis for a study assessing the effectiveness of two different doses of RPC1063 (Receptos, Inc.), an experimental oral therapy, and Avonex® (interferon beta-1a, Biogen Inc.) in order to reduce relapse rate in patients. This study, called the Sunbeam Study, is being funded by…

Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients

Roche recently announced encouraging results on its investigational medicine ocrelizumab as a therapy for patients with relapsing multiple sclerosis, which includes either RRMS or SPMS with relapses. Ocrelizumab was evaluated in two pivotal studies (OPERA I and OPERA II), where it was compared to interferon (IFN) beta-1a (Rebif®), the standard-of-care…

“MS” Documentary Released on YouTube

“MS” is a documentary film released last year that tells the story of three patients who suffer from multiple sclerosis (MS) and how they deal with the chronic debilitating disease. The director of the film recently announced that the short documentary has been made available on YouTube in…

MS Views and News Seeks to Improve MS Education in July

MS Views and News (MSVN) is a non-profit organization that works at collecting, presenting and distributing information about multiple sclerosis (MS) as well as improving knowledge and education among patients and other members of the MS community. During July, MS Views and News will host four events featuring medical…

Innovative “Nanoprobe” Used to Diagnose Multiple Sclerosis

A nanometric sensor — an extremely small probe originally designed to test samples for the presence of herbicides, heavy metals, and pollutants — was experimentally shown to also detect molecules commonly associated with multiple sclerosis. Physicist Fábio de Lima Leite, a professor at the Federal University of São Carlos (UFSCar),…

LMU Researchers Identify Biomarker BCMA to Measure MS Severity

In a recent study published in the journal Nature Communications, LMU clinicians have clarified the lifespan of antibody-producing cells and have also identified a novel biomarker that could be used to monitor autoimmune conditions such as multiple sclerosis and lupus erythematous. The humoral immune response is mediated by cells…

MS Views and News Hosting Events for MS Community in July

MS Views and News (MSVN), a non-profit organization that works to improve education, advocacy and service to empower and enhance the quality of life of patients who suffer from multiple sclerosis (MS), has announced it will offer a series of educational events on different topics throughout the month of July in…

MediciNova Announces Update On Phase 2b Trial of MN-166 (Ibudilast) Involving 255 Progressive MS Patients

MediciNova, Inc., a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs, recently announced that the ongoing clinical trial of MN-166 (ibudilast) in patients with progressive multiple sclerosis (progressive MS) has finished the randomization of 255 patients, exceeding…

MS Health Care Excellence Awards Launched in UK

UK-based MS Trust has announced the launch of new awards designed to distinguish healthcare professionals that are committed to treating and changing the lives of patients who suffer from multiple sclerosis (MS). The QuDos Awards are currently open for nominations and will feature ten different categories. The QuDoS in MS Awards –…

Multiple Sclerosis Community Celebrates World MS Day

World MS Day is celebrated on May 27 as a day dedicated to those who suffer from multiple sclerosis (MS). In order to mark the occasion, organizations, companies, advocates, and communities are hosting events throughout the world to share inspiring stories, raise awareness about the disease and campaign to support both patients…

Progressive MS Challenges to Be Dicussed at CMSC Meeting

The needs of patients who suffer from progressive multiple sclerosis (MS) will be addressed in a presentation hosted by Alan Thompson, MD, FRCP, from the University College London (UCL) during the Donald Paty Memorial Lecture. The Lecture will take place during the Consortium of Multiple Sclerosis Centers (CMSC) 29th Annual…

The Multiple Sclerosis Podcast



Video